Evidence map›Paper›PMID 30390070›Full record

ArticleOncogene2019

Correction: ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling.

Vincent C Pai, Chung-Chi Hsu, Tze-Sian Chan, Wen-Ying Liao, Chih-Pin Chuu, Wei-Yu Chen, Chi-Rong Li, Ching-Yu Lin, Shu-Pin Huang, Li-Tzong Chen and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Vincent C PaiGraduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City, 11031, Taiwan.
Chung-Chi HsuGraduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City, 11031, Taiwan.
Tze-Sian ChanGraduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City, 11031, Taiwan.
Wen-Ying LiaoNational Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli County, 35053, Taiwan.
Chih-Pin ChuuInstitute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Miaoli County, 35053, Taiwan.
Wei-Yu ChenDepartment of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei City, 11696, Taiwan.
Chi-Rong LiDepartment of Teaching and Research, Taichung Hospital Ministry of Health and Welfare, Taichung City, 40343, Taiwan.
Ching-Yu LinInstitute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Miaoli County, 35053, Taiwan.
Shu-Pin HuangDepartment of Urology, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, 80756, Taiwan.
Li-Tzong ChenNational Institute of Cancer Research, National Health Research Institutes, Zhunan, Miaoli County, 35053, Taiwan.
Kelvin K TsaiGraduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei City, 11031, Taiwan. tsaik@tmu.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the published version of this paper the author Shu-Pin Huang's surname was incorrectly given as Hwang instead of Huang. This has now been corrected in the HTML and PDF versions of the paper.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.